KUR Research has developed the largest and most geographically diverse, infectious disease biobank. Our biobank is focused on delivering large medical and pharmaceutical companies with a variety of human biological specimens. By purchasing samples directly from KUR Research, the companies we service can avoid the lengthy process of procuring samples through a clinical trial. Vexillum currently holds numerous infectious disease biospecimens including SARS-CoV-2, Influenza A, and Influenza B. Our diverse site list allows us to easily collect healthy control samples for all your research and development needs.

Not finding what you need in our banked specimens? Vexillum can easily begin a biospecimen collection to accommodate your specific needs. Our collection sites are IRB approved and ready to collect immediately. Vexillum protocol allows for the collection of various Human Biospecimens including saliva, whole blood, serum, plasma, vaginal swabs, anterior nasal swabs, nasopharyngeal swabs, urine and many more.

Our largest project has been the prospective collection of 1000 donors suspected of Acute Upper Respiratory Infestion. The method for this collection was a combination of an all-comers collection and an enriched patient population utilizing standard of care rapid antigen testing. This project was completed in 90 days. To date, the participating sites have been the associated KUR urgent care centers and multidisciplinary private practices.

All samples available for purchase are collected by trained and delegated clinical research staff utilizing an IRB approved protocol for specimen procurement. Each donor signs IRB approved Informed Consent prior to donation. Let us know how we can support your research, Vexillum is making progress possible.